ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: PO1572

Feasibility and Acceptability of Home Urinalysis Monitoring Using a Smartphone Application

Session Information

Category: Glomerular Diseases

  • 1203 Glomerular Diseases: Clinical, Outcomes, and Trials


  • Levy Erez, Daniella, The Children's Hospital of Philadelphia, Philadelphia, United States
  • Derwick, Hannah C., The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
  • Furth, Susan L., The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
  • Ballester, Lance S., The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
  • Mink, Jonah, Healthy IO, Tel Aviv, Israel
  • Omuemu, Stephanie, Healthy IO, Tel Aviv, Israel
  • Denburg, Michelle, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Monitoring proteinuria in patients with kidney disease is of crucial importance given its implications for long term disease progression and clinical management. As part of efforts to encourage test adherence, leveraging technology to provide a clinical grade urinalysis result from a home test can greatly enhance the clinical experience for patients, caregivers and providers.


Children and young adults (5-21 yrs old) at a single pediatric center participated. Caregivers or patients (>12yrs) completed a brief survey and then received a home urinalysis kit by mail. The smartphone app uses advanced computer vision to assess the urinalysis dipstick using the smartphone camera. Families downloaded the app through a text message link and performed a home urine test followed by a survey about their experience.Urine results immediately appeared in the app for patients and accessed by the study team through a secure portal. Patient satisfaction was compared between the new app and current practice (home albustix or a urine sample brought to clinic) using Wilcoxon rank test with a p value <0.05. Free text responses were analyzed to identify themes related to the app experience.


103 children, 63 (61%) male, median age 10.9 yrs. (IQR 7.8-14.2) were enrolled. Primary diagnosis included: 47 (46%) glomerular disease, 48 (47%) non-glomerular disease and 8 (8%) kidney transplant recipients. 101(98%) patients were satisfied with the smartphone app compared to 41(40%) patients who were satisfied with the current practice P<0.0001. (Table 1) Patients’ free text comments were divided into themes in table 2.


The home urine testing app received very high rates of satisfaction among patients and caregivers compared to current practice and holds great potential to enhance patient-centered care.


  • Commercial Support